Mustang Bio Inc (MBIO)
0.5531
+0.07
(+14.18%)
USD |
NASDAQ |
Jul 02, 16:00
0.52
-0.03
(-5.98%)
After-Hours: 17:02
Mustang Bio Research and Development Expense (TTM): 30.84M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 30.84M |
| December 31, 2023 | 41.04M |
| September 30, 2023 | 51.40M |
| June 30, 2023 | 57.33M |
| March 31, 2023 | 61.66M |
| December 31, 2022 | 63.95M |
| September 30, 2022 | 64.38M |
| June 30, 2022 | 63.64M |
| March 31, 2022 | 60.38M |
| December 31, 2021 | 55.71M |
| September 30, 2021 | 56.57M |
| June 30, 2021 | 50.13M |
| March 31, 2021 | 49.36M |
| December 31, 2020 | 47.30M |
| September 30, 2020 | 42.84M |
| June 30, 2020 | 42.58M |
| Date | Value |
|---|---|
| March 31, 2020 | 38.47M |
| December 31, 2019 | 36.32M |
| September 30, 2019 | 32.67M |
| June 30, 2019 | 30.97M |
| March 31, 2019 | 27.51M |
| December 31, 2018 | 24.46M |
| September 30, 2018 | 26.85M |
| June 30, 2018 | 23.02M |
| March 31, 2018 | 23.46M |
| December 31, 2017 | 20.38M |
| September 30, 2017 | 14.59M |
| June 30, 2017 | 12.67M |
| March 31, 2017 | 9.261M |
| December 31, 2016 | 8.547M |
| September 30, 2016 | 2.481M |
| June 30, 2016 | 2.482M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
30.84M
Minimum
Mar 2024
64.38M
Maximum
Sep 2022
49.82M
Average
50.13M
Median
Jun 2021
Research and Development Expense (TTM) Benchmarks
| Fortress Biotech Inc | 91.40M |
| AIM ImmunoTech Inc | 10.84M |
| Perspective Therapeutics Inc | 24.91M |
| Protalix BioTherapeutics Inc | 14.13M |
| Armata Pharmaceuticals Inc | 32.18M |